Results 301 to 310 of about 119,230 (327)
Some of the next articles are maybe not open access.
Restenosis: a challenge for pharmacology
Trends in Pharmacological Sciences, 2000The quest for an anti-restenotic drug continues to be a major challenge in the field of cardiovascular pharmacology because most therapies with proven efficacy in experimental neointima models have failed to limit restenosis. Some drug classes, including glycoprotein IIb/IIIa antagonists, nitric oxide donors and the antioxidant probucol, have recently ...
openaire +4 more sources
Mechanisms of drug-eluting stent restenosis
Cardiovascular Intervention and Therapeutics, 2020J. Aoki, K. Tanabe
semanticscholar +1 more source
Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.
New England Journal of Medicine, 1987U. Sigwart+4 more
semanticscholar +1 more source
Restenosis and in-stent restenosis
2008David J. Moliterno, Nezar M. Falluji
openaire +2 more sources
Therapeutic Options for In-Stent Restenosis
Current Cardiology Reports, 2018C. Nicolais+6 more
semanticscholar +1 more source
Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study.
Circulation, 1996Rainer Hoffmann+8 more
semanticscholar +1 more source